Treatment Guidelines for Nodular Toxic Goiter

Initial Medical Management

• The American College of Endocrinology recommends initiating methimazole to control hyperthyroidism while preparing for definitive therapy with either radioactive iodine or thyroidectomy, with methimazole serving as bridge therapy before surgery or radioactive iodine, and monitoring for side effects including agranulocytosis, particularly in the first 3 months 1

Diagnostic Workup Before Definitive Treatment

• Obtain radionuclide uptake scan (preferably I-123) to confirm hyperfunctioning nodules and verify the entire goiter consists of thyroid tissue, and compare ultrasound findings with radionuclide scan to identify any nodules requiring fine needle aspiration biopsy 1
• Measure free T3 and free T4 to determine hyperthyroidism severity, and do not rely solely on Doppler ultrasound to differentiate thyrotoxicosis causes—radionuclide uptake study directly measures thyroid activity 1
• If compressive symptoms present (dyspnea, dysphagia, dysphonia), obtain CT neck without contrast to evaluate substernal extension and tracheal compression 2, 1

Definitive Treatment Selection Algorithm

• Choose surgery (total or near-total thyroidectomy) if large goiter with compressive symptoms, suspicious nodules requiring histological evaluation, substernal extension confirmed on CT scan, young patient with long life expectancy, or previous neck surgery/radiation making future intervention risky 1
• Choose radioactive iodine (I-131) if elderly patient or significant surgical comorbidities, patient preference to avoid surgery, smaller goiter without significant compressive symptoms, and avoid iodinated contrast agents before RAI as they interfere with iodine uptake 1

Post-Treatment Management

• Monitor thyroid function tests every 4-6 weeks initially, then every 3-6 months after radioactive iodine, and initiate levothyroxine replacement if hypothyroidism develops 1
• Initiate levothyroxine replacement immediately postoperatively after total thyroidectomy, and monitor calcium levels for hypoparathyroidism 1
• In expert hands, complications (laryngeal nerve palsy, hypoparathyroidism) occur in <1-2% of cases after total thyroidectomy 3

Alternative Therapies for Select Patients

• Thermal ablation (radiofrequency or microwave) may be considered for autonomously functioning adenomas in patients unfit for surgery or refusing traditional treatment, though this is primarily established for benign nodules 4, 5

Critical Pitfalls to Avoid

• Do not delay treatment in elderly patients—cardiac complications, particularly atrial fibrillation, are significant risks 1

Management of Toxic Autonomously Functioning Thyroid Nodules with Subclinical Hyperthyroidism

Diagnostic Evaluation

• Obtain and review the patient’s prior thyroid ultrasound images to determine the size of the hot nodule and to look for any suspicious sonographic features (e.g., hypoechogenicity, microcalcifications, irregular margins). 6
• Perform fine‑needle aspiration biopsy of any nodule that appears “cold” on radionuclide scanning or that shows suspicious ultrasound characteristics, because co‑existing cold nodules can be malignant even when a hot nodule is present. 6
• Correlate radionuclide scan findings with ultrasound, since approximately 5–10 % of thyroid nodules harbor malignancy. 6, 7
• Avoid iodinated contrast agents for 4–8 weeks before administering radioactive iodine (I‑131), as contrast interferes with iodine uptake. 6

Risk Stratification

• A profoundly suppressed TSH (< 0.1 mIU/L) is associated with a markedly higher risk of atrial fibrillation, heart failure, osteoporosis, and overall mortality compared with patients whose TSH is 0.1–0.4 mIU/L. 8

Treatment Recommendations

• Treat subclinical hyperthyroidism when TSH is < 0.1 mIU/L, especially in individuals older than 65 years or those with cardiovascular risk factors. 8

Imaging and Diagnostic Recommendations for Toxic Thyroid Adenoma

Radionuclide Scintigraphy

• The American College of Radiology recommends performing a radionuclide uptake scan—preferably with I‑123 rather than I‑131 because of superior image quality—to confirm a hyperfunctioning (“hot”) nodule and to ensure that the entire gland consists of thyroid tissue before definitive therapy. [9][10]

• Hot nodules appear “hot” on scintigraphy because they concentrate radiotracer more avidly than surrounding suppressed thyroid tissue, reflecting autonomous hormone production. [9][10]

Ultrasound Correlation and Biopsy Guidance

• The American College of Radiology advises that radionuclide scan findings be correlated with thyroid ultrasound to detect any cold or isofunctioning nodules; these nodules should undergo fine‑needle aspiration because 5–10 % of thyroid nodules harbor malignancy even when a hot nodule is present. 9

• Ultrasound is also required to obtain thyroid dimensions for calculating radioactive‑iodine dosing and to evaluate suspicious sonographic features (e.g., hypoechogenicity, microcalcifications, irregular margins). 9

Avoiding Misinterpretation of Doppler Ultrasound

• The American College of Radiology cautions that Doppler ultrasound alone should not be used to differentiate causes of thyrotoxicosis; radionuclide uptake studies are the gold standard for directly measuring thyroid activity. 9

Fine‑Needle Aspiration Recommendations

• According to the American College of Radiology, fine‑needle aspiration should not be performed on hot nodules, but any cold or isofunctioning nodules identified on scintigraphy must be biopsied because malignancy can coexist. 9

Imaging for Compressive Symptoms

• When patients present with compressive symptoms (e.g., dyspnea, dysphagia, dysphonia), the American College of Radiology recommends a non‑contrast CT of the neck to assess substernal extension and possible tracheal compression. 9